Clinical Impact of a Next-Generation Sequencing Approach for Glioblastoma Patients.

Cancers (Basel) · 2025 · PMC11898826 · PMID 40075591

Europe PMC DOI

hedged sentence

0.0551

closest p · 1.1× alpha

0.0551

boldest claim

The sentences

showed a trendp = 0.0551so close (0.05 < p ≤ 0.1)

Postoperative contrast-enhancing tumor volumetry showed a trend towards longer survival for smaller postoperative volumes ( p = 0.0551).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.